Search

Search Constraints

You searched for: Author/Creator McLauchlan, John

Search Results

2. Antiviral treatment in patients with advanced hepatitis C virus cirrhosis with sofosbuvir and either ledipasvir or daclatasvir, with or without ribavirin: observational cohort study. (25th February 2016)

3. Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK. Issue 7 (July 2021)

4. Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study. Issue 10296 (17th July 2021)

6. Comprehensive Comparative Analysis of Standard Validated, Genetic, and Novel Biomarkers to Enhance Prognostic Risk-Stratification in Patients With Hepatitis C Virus Cirrhosis. Issue 3 (9th March 2022)

7. Consensus recommendations for resistance testing in the management of chronic hepatitis C virus infection: Public Health England HCV Resistance Group. Issue 6 (December 2019)

9. Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study. Issue 4 (April 2021)

10. Geographical variation in hepatitis C-related severe liver disease and patient risk factors: a multicentre cross-sectional study. (14th March 2023)